Croda International (CRDA) Stock Overview
Engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
CRDA Community Fair Values
See what 44 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Croda International Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£29.01 |
| 52 Week High | UK£33.12 |
| 52 Week Low | UK£24.27 |
| Beta | 0.91 |
| 1 Month Change | 1.36% |
| 3 Month Change | 4.84% |
| 1 Year Change | -4.19% |
| 3 Year Change | -44.99% |
| 5 Year Change | -58.82% |
| Change since IPO | 1,710.78% |
Recent News & Updates
CRDA: Margin Execution And Multiple Support Will Drive Reappraisal Over Time
Analysts have lifted their price target on Croda International by around £1, reflecting slightly higher fair value estimates, modestly adjusted revenue growth and margin assumptions, and a small change in expected future P/E multiples following a series of recent upgrades offset by at least one target cut. Analyst Commentary Bullish Takeaways Bullish analysts have upgraded Croda International, indicating greater confidence that the current share price may not fully reflect their revised fair value estimates.CRDA: Mixed Broker Upgrades And Execution Risks Will Shape Future P/E Expectations
Analysts have adjusted their price targets on Croda International to around £32.80. This reflects updated assumptions on revenue growth, profit margins and future P/E multiples following a series of recent rating upgrades and target tweaks across the Street.CRDA: Cluster Of Recent Upgrades Will Support Re Rating Potential
The updated analysis trims Croda International's fair value estimate slightly to £47.67 from £47.96, as analysts factor in recent target changes and upgrades that reflect adjusted assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Croda International has leaned constructive, with several bullish analysts adjusting ratings and targets in quick succession.Recent updates
Shareholder Returns
| CRDA | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | -4.6% | -3.2% | -0.7% |
| 1Y | -4.2% | 4.7% | 16.7% |
Return vs Industry: CRDA underperformed the UK Chemicals industry which returned 6.9% over the past year.
Return vs Market: CRDA underperformed the UK Market which returned 17.3% over the past year.
Price Volatility
| CRDA volatility | |
|---|---|
| CRDA Average Weekly Movement | 4.2% |
| Chemicals Industry Average Movement | 7.7% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in GB Market | 11.7% |
| 10% least volatile stocks in GB Market | 3.2% |
Stable Share Price: CRDA has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: CRDA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1925 | 5,954 | Steve Foots | www.croda.com |
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers consumer care products across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, crop protection, and seed coating systems and enhancement technologies to improve germination.
Croda International Plc Fundamentals Summary
| CRDA fundamental statistics | |
|---|---|
| Market cap | UK£4.06b |
| Earnings (TTM) | UK£62.00m |
| Revenue (TTM) | UK£1.70b |
Is CRDA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRDA income statement (TTM) | |
|---|---|
| Revenue | UK£1.70b |
| Cost of Revenue | UK£953.70m |
| Gross Profit | UK£745.70m |
| Other Expenses | UK£683.70m |
| Earnings | UK£62.00m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Jul 28, 2026
| Earnings per share (EPS) | 0.44 |
| Gross Margin | 43.88% |
| Net Profit Margin | 3.65% |
| Debt/Equity Ratio | 28.1% |
How did CRDA perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/05 12:21 |
| End of Day Share Price | 2026/06/05 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Croda International Plc is covered by 32 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| James Knight | Barclays |
| Katie Richards | Barclays |
| Amy Lian | Barclays |